A growing number of patients develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of standard modifiable risk factors (SMuRF-less). There is scarcity of studies that address this issue in the Middle Eastern population.
Atherosclerotic coronary artery disease (ASCAD) claims millions of lives annually on a global level and is the leading cause of death in the Middle East. There are four standard modifiable cardiovascular risk factors (SMuRFs): hypertension, type 2 diabetes mellitus, dyslipidemia, and smoking. These are very common in the Middle East and are crucial to be screened for and addressed in an affective manner. However, an increasing proportion of patients with ASCVD have none of these individual factors (SMuRF-less). Globally, this proportion comprises 11.6% of individuals with stable coronary disease and heart attack. No prior study has addressed the issue of the prevalence of SMuRF-less patients among the whole population of individuals with ASCVD in the Middle East.
Study Type
OBSERVATIONAL
Enrollment
5,540
Individuals identified with a diagnosis of ASCVD will fill a one page form of the associated risk factors they have
Istishari Hospital
Amman, Jordan
Yarmouk University School of Medicine
Irbid, Jordan
Prevalence of patients who do not any of the four SMuRFs
Group of patients with definite ASCVD who do not have hypertension, diabetes, dyslipidemia or smoking.
Time frame: Up to 4 weeks after study enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.